JERUSALEM Nov 28 Israel's Teva Pharmaceuticals
has partnered with Tel Aviv-based Syqe Medical to
market in Israel medical cannabis for pain management that is
administered with an inhaler.
The companies said in a statement on Monday that this is the
first time the medical cannabis sector has complied with
pharmaceutical standards for inhalation, which is the most
efficient means for administering the plant.
Teva, the world's largest generic drugmaker, will be the
exclusive marketer and distributor in Israel of the inhaler
developed by Syqe Medical. It will be available for home use
pending approvals from the country's Ministry of Health.
(Reporting by Ari Rabinovitch)